AZD5718 oral suspension
Sponsors
AstraZeneca
Conditions
Coronary Artery DiseaseHigh Risk Coronary Artery Disease
Phase 1
A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet
CompletedNCT02963116
Start: 2016-12-20End: 2017-03-01Updated: 2017-03-09
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men
CompletedNCT03400488
Start: 2018-01-16End: 2018-06-12Updated: 2018-06-15